Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 37 entries
View as:

Comparison of the Efficacy of Inflexal V With a Commercially Available Influenza Vaccine in Young Children

Phase: N/A Priority: Normal
NCT ID: NCT01310400 Org: User:
Start: 10/31/09 End: 01/31/10 Due: 01/31/11

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains

Phase: N/A Priority: Normal
NCT ID: NCT01631110 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13

Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

Phase: N/A Priority: Normal
NCT ID: NCT01631071 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13

Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B

Phase: N/A Priority: Normal
NCT ID: NCT01362517 Org: User:
Start: 04/30/10 End: 04/30/11 Due: 04/30/12

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere

Phase: N/A Priority: Normal
NCT ID: NCT01303510 Org: User:
Start: 07/31/08 End: 07/31/08 Due: 07/31/09

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere

Phase: N/A Priority: Normal
NCT ID: NCT01306253 Org: User:
Start: 06/30/09 End: 06/30/09 Due: 06/30/10

Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses

Phase: N/A Priority: Normal
NCT ID: NCT01756950 Org: User:
Start: 01/31/13 End: 11/30/13 Due: 11/30/14

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02148328 Org: User:
Start: 05/31/14 End: 10/31/14 Due: 10/31/15

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

Phase: N/A Priority: Normal
NCT ID: NCT01992276 Org: User:
Start: 12/31/13 End: 02/28/15 Due: 02/28/16

Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns

Phase: N/A Priority: Normal
NCT ID: NCT01349283 Org: User:
Start: 05/31/11 End: 11/30/13 Due: 11/30/14

A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02313077 Org: User:
Start: 12/17/14 End: 03/15/16 Due: 03/15/17

Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01357720 Org: User:
Start: 05/31/11 End: 09/30/11 Due: 09/30/12

A Study to Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02376426 Org: User:
Start: 03/31/15 End: 06/30/16 Due: 06/30/17

A Study to Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT02543268 Org: User:
Start: 09/21/15 End: 07/20/16 Due: 07/20/17

Safety and Immunogenicity of a Paediatric Dose of Virosomal Hepatitis A Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01405677 Org: User:
Start: 06/30/04 End: 04/30/12 Due: 04/30/13

Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients

Phase: N/A Priority: Normal
NCT ID: NCT01839760 Org: User:
Start: 12/31/12 End: 01/31/14 Due: 01/31/15

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)

Phase: N/A Priority: Normal
NCT ID: NCT01893177 Org: User:
Start: 07/31/13 End: 08/31/13 Due: 08/31/14

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Phase: N/A Priority: Normal
NCT ID: NCT01938352 Org: User:
Start: 10/02/13 End: 01/22/14 Due: 01/22/15

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT02440035 Org: User:
Start: 04/21/15 End: 06/09/16 Due: 06/09/17

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02561871 Org: User:
Start: 09/30/15 End: 09/30/16 Due: 09/30/17

Assessment of CR6261, a Monoclonal Antibody Against the Influenza A Virus

Phase: N/A Priority: Normal
NCT ID: NCT01406418 Org: User:
Start: 02/28/13 End: 11/30/13 Due: 11/30/14

A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children

Phase: N/A Priority: Normal
NCT ID: NCT01349829 Org: User:
Start: 03/31/10 End: 04/30/11 Due: 04/30/12

Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01228383 Org: User:
Start: 12/31/11 End: 12/31/12 Due: 12/31/13

A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00656097 Org: User:
Start: 03/31/08 End: 07/31/08 Due: 07/31/09

A Study to Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02376400 Org: User:
Start: 04/30/15 End: 09/30/16 Due: 09/30/17